NSE: AARTIIND | BSE: 524208

Mid-range Performer

Download real time

466.70 -1.90 (-0.41%)

39.03% Fall from 52W High

2.0M NSE+BSE Volume

NSE 13 May, 2025 3:59 PM (IST)

16,918.8

Market Cap

High in industry

1.3

Beta 1Year

Very High Volatility

Aarti Industries Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for AARTIIND, BSE:524208 Aarti Industries Ltd.

Aarti Industries Ltd.

20 May 2021

466.70

-0.41%

Aarti Industries

Buy: Aarti Industries Ltd.

Target

ICICI Securities Limited

Q4 numbers were impacted by annual shutdown and commissioning of new plants. Demand for speciality chemical has almost reached to pre-COVID level. Based on visibility, the management has given ambitious revenues, EBIT and PAT guidance of 1.7-2x growth from FY21-24E. Leveraging on core knowledge of benzene-based derivatives, the company is continuously expanding product basket towards value added products covering the entire value chain. In pharma, strong growth is expected from developed markets backed by integrated model and new launches. Margins are also expected...

Promoters pledged 0.01% of shares in last quarter. Total pledge stands at 3.56% of promoter holdings

Aarti Industries Ltd.

05 Apr 2021

466.70

-0.41%

Pick of the Week - Aarti Industries Limited

Buy: Aarti Industries Ltd.

Edelweiss

Aarti Industries Limited is a well-diversified chemicals company.

Aarti Industries Ltd. has gained 21.87% in the last 1 Month

Aarti Industries Ltd.

11 Feb 2021

466.70

-0.41%

Indian Chemical Sector: The silver lining

Buy: Aarti Industries Ltd.

Target

HDFC Securities

We maintain BUY on AIL, Galaxy Surfactants, Sudarshan Chemical; ADD on NFIL, Balaji Amines, Alkyl Amines, SRF; while maintaining SELL on Vinati Organics. We are also initiating coverage on Fine Organic and NOCIL with a BUY and Deepak Nitrite with an ADD recommendation. The first half of CY20 was an unanticipated turning point for the chemical industry. The dual effects of the COVID-related economic downturn and disruption in chemical supply chain impacted the industry adversely. However, this sector was amongst the first few that returned to normalcy. We have assessed the current situation of the industry and our analysis compels us to uphold our positive stance on our specialty chemicals universe.

Promoters pledged 0.01% of shares in last quarter. Total pledge stands at 3.56% of promoter holdings

Aarti Industries Ltd.

04 Feb 2021

466.70

-0.41%

AARTI INDUSTERIES LTD

Accumulate: Aarti Industries Ltd.

Target

Geojit BNP Paribas

AARTI Industries Ltd (ARTO) is a global leader in Benzene based derivative products. The company has a diversified product portfolio with end users in pharma, agrochemicals, specialty polymers, paints & pigments. Q3FY21 revenue grew by 10% YoY, led by strong off-take from Pharma segment, which grew by ~32% YoY....

Aarti Industries Ltd. is trading above its 150 day SMA of 440.4

Aarti Industries Ltd.

04 Feb 2021

466.70

-0.41%

Light House Update - A Quick Perspective - Aarti Industries Ltd. - 04 February 2021

Accumulate: Aarti Industries Ltd.

Way2Wealth

EBITDA for the quarter stood at `2,850mn showcasing growth of ~12% Y-o-Y and 12% Q-o-Q and EBITDA margins improved to ~24.0% in Q3FY21 from 23.5% in Q3FY20. Company recorded highest gross margin ~54.1% up 303 bps...

Aarti Industries Ltd. has lost -30.62% in the last 1 Year

Aarti Industries Ltd.

02 Feb 2021

466.70

-0.41%

Result Update:Aarti Industries

Buy: Aarti Industries Ltd.

Target

Axis Direct

We maintain BUY and update Target Price to Rs. 1,298 /share valued at 27x of FY23E EPS of Rs. 48.9

Promoters pledged 0.01% of shares in last quarter. Total pledge stands at 3.56% of promoter holdings

Aarti Industries Ltd.

31 Jan 2021

466.70

-0.41%

Aarti Industries

Buy: Aarti Industries Ltd.

Target

ICICI Securities Limited

Aggressive expansion to support long term growth Aarti has spent | 3000+ crore in capex in FY17-20, on three multiyear projects. Of this, one was recently cancelled (expects to receive | 900-975 crore as compensation) while the remaining two projects have multiyear peak annual potential of | 590 crore (exhibit 3). Apart from this, it has spent on new R&D; unit, expansion of hydrogenation, NCB, de-bottlenecking in various specialty chemicals, and pharma. Going ahead, Aarti is likely to spend at least | 1000-1200 crore per annum in the next four to six years to...

Aarti Industries Ltd. is trading above its 150 day SMA of 440.4

Aarti Industries Ltd.

18 Nov 2020

466.70

-0.41%

Aarti Ind

Accumulate: Aarti Industries Ltd.

Recommendation Target

Dolat Capital

Next leg of Aarti's growth will ride on long-term contracts worth Rs110bn, which has been delayed and will start from Q1FY22E. We tweak our FY21 estimates to factor delay in commissioning of long term contract and make other changes. AIL's near term growth trajectory will face...

Aarti Industries Ltd. has gained 21.87% in the last 1 Month

Aarti Industries Ltd.

13 Nov 2020, 12:00AM

466.70

-0.41%

Light House Update - A Quick Perspective - Aarti Industries Ltd. - 13 November 2020

Accumulate: Aarti Industries Ltd.

Way2Wealth

Aarti Industries Ltd reported ~19% YoY and ~25% QoQ increase in topline to `11,726mn on account of 24% YoY and 32% QoQ increase in specialty chemicals segment and ~21% YoY and 14% QoQ increase in pharmaceuticals. EBITDA for the quarter stood at `2543mn showcasing growth of ~0.5% YoY and 39% QoQ. However, EBITDA margins dropped to 21.7% in Q2FY21 compared to...

Aarti Industries Ltd. is trading above its 150 day SMA of 440.4

Aarti Industries Ltd.

13 Nov 2020, 12:00AM

466.70

-0.41%

Aarti Ind

Buy: Aarti Industries Ltd.

Target

KRChoksey

Aarti Industry's specialty chemicals volume growth was driven by sales push in non-regular market for its discretionary products. Pharma segment continues to grow its volume with demand being intact resulting in better operating leverage for the company. Overall revenue increased on account of increasing volume and greater traction from customer, based on scale-up of value-added products. Specialty chemical segment EBIT margin contracted 676 bps YoY / (up 172 bps QoQ) to 17.1% due to one-time effort to push higher volume at lower margin, while that of Pharma segment expanded 700 bps / 219 bps QoQ to 25.5%, resulting in overall EBIT margin contraction by 445 bps YoY (up 163 bps QoQ)....

Aarti Industries Ltd. has lost -30.62% in the last 1 Year

Is Aarti Industries Ltd. worth buying?

866 Votes:

Buy 80.6%

Sell 11.55%

Hold 7.85%

RESEARCH REPORTS

Sell SEE REPORTS >

pdf

Buy SEE REPORTS >

pdf